"We considered it only a question of time before the pharmaceutical market and the country’s economy would fully recover and deliver on their promise."
In Conversation
"The response from medical professionals has been extremely positive and the hard work we did many years ago to ensure we only sell easy-to-use high quality…
"Overall, Bioscience Group is partnering with over 50 pharmaceutical and healthcare companies – a large share of them being located in the EU."
"Despite constraints faced by the industry through reimbursement reforms that have recently been put in place, Austria enhances innovation by giving companies opportunities for early launches."
"Fundamentally, Roche Diagnostics invests heavily in people to support their growth and this ultimately contributes to the company’s success."
"Asia Pacific contributes more than 25% of our global pharmaceuticals sales, which is a significant portion: in 2016, we reported a sales increase of 8.6% to…
"There are three main areas [of concern for our members]: transparency, pricing and access."
"Cirina and Grail have pretty much the same goals. We aim to detect cancer at a stage where it is still possible to do something"
Roman Gladkyi, general manager of Ferring Ukraine, describes the current opportunities and areas for improvement he identifies within Ukraine’s pharmaceutical market and the country’s evolving heath…
"Hong Kong is in a sweet spot because we are part of the world’s second largest economy. Under the ‘One Country, Two systems’ approach, we have…
"Overall, we are a major success story thanks to our unique interdisciplinarity concept of research, combining experts from many different fields, such as basic science, medical…
"Hong Kong had initially been seen as a next-tier market because of its size but I quickly realized when I arrived that the public healthcare system…
